Eleva UCITS Eleva Eurp Sel I EUR acc |
Performance History | 30/11/2024 |
Growth of 1,000 (EUR) |
Fund | 3.2 | 28.3 | -10.8 | 17.1 | 12.0 | |
+/-Cat | 4.4 | 5.4 | 2.4 | 2.9 | 4.7 | |
+/-Idx | 6.1 | 2.9 | -1.1 | 1.2 | 2.5 | |
Category: Europe Large-Cap Blend Equity | ||||||
Benchmarks: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 19/12/2024 | EUR 2237.44 | |
Day Change | -1.55% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU1111643042 | |
Fund Size (Mil) 19/12/2024 | EUR 6507.80 | |
Share Class Size (Mil) 19/12/2024 | EUR 2578.07 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 09/12/2024 | 0.90% |
Investment Objective: Eleva UCITS Eleva Eurp Sel I EUR acc |
The Fund seeks to achieve superior long-term risk adjusted returns and capital growth by investing primarily in European equities and equity related securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Armand d’Albufera 26/01/2015 | ||
Eric Bendahan 26/01/2015 | ||
Inception Date 26/01/2015 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
STOXX Europe 600 NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Eleva UCITS Eleva Eurp Sel I EUR acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 4.62 |
SAP SE | Technology | 3.06 |
Schneider Electric SE | Industrials | 2.92 |
Intesa Sanpaolo | Financial Services | 2.83 |
Sanofi SA | Healthcare | 2.59 |
Increase Decrease New since last portfolio | ||
Eleva UCITS Eleva Eurp Sel I EUR acc |